Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Graft-vs-host-disease (GVHD): Signs, Symptoms, and Treatment

    ... cells ( stem cells ) donated by someone else. Graft-versus-host disease (GVHD) is a common, and sometimes serious, side effect of an ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  2. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    ... Purpose:  Acute Graft-versus-Host-Disease (GVHD) is an important cause of morbidity and mortality after ...

    Clinical Trial last updated 06/06/2016 - 1:59pm.

  3. A Phase II Trial of CD24Fc for Prevention of Acute Graft-versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplant

    ... the MTD (Maximum Tolerated Dose) of CD24Fc for acute GVHD (Graft Versus Host Disease) prophylaxis. Status:  ...

    Clinical Trial last updated 04/29/2016 - 11:03am.

  4. Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

    ... randomized phase III trial studies how well graft-vs-host disease (GVHD) prophylaxis works in treating patients with hematologic malignancies ...

    Clinical Trial last updated 04/28/2016 - 1:49pm.

  5. Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant

    ... and mycophenolate mofetil works in preventing graft-vs-host disease (GVHD) in patients with hematologic malignancies undergoing donor peripheral ...

    Clinical Trial last updated 04/28/2016 - 12:07pm.

  6. Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

    ... donor atorvastatin treatment works in preventing severe graft-versus-host disease (GVHD) after nonmyeloablative peripheral blood stem cell (PBSC) ...

    Clinical Trial last updated 05/03/2016 - 9:44am.

  7. Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis

    ... in the post transplant setting to prevent onset of acute graft-versus-host disease (GVHD) . The primary objective is to determine the incidence of ...

    Clinical Trial last updated 04/27/2016 - 9:38am.

  8. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... Purpose:  Graft-versus-host disease (GVHD) is a condition that results from a reaction of transplanted ...

    Clinical Trial last updated 04/27/2016 - 8:55am.

  9. Clinical Trials Report for April 2016

    ... in the post transplant setting to prevent onset of acute graft-versus-host disease (GVHD) . The primary objective is to determine the incidence of ...

    Page last updated 08/10/2016 - 11:00am.

  10. Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    ... cells in patients with leukemia, MDS, lymphoma, Hodgkin disease, or MM, after they have received an allogeneic stem cell transplant ... want to learn if giving AP1903 will help the symptoms of graft-versus-host disease (GvHD) that may occur after the T-cell infusion. ...

    Clinical Trial last updated 06/06/2016 - 12:41pm.